114 related articles for article (PubMed ID: 17335344)
1. PPARalpha siRNA-treated expression profiles uncover the causal sufficiency network for compound-induced liver hypertrophy.
Dai X; De Souza AT; Dai H; Lewis DL; Lee CK; Spencer AG; Herweijer H; Hagstrom JE; Linsley PS; Bassett DE; Ulrich RG; He YD
PLoS Comput Biol; 2007 Mar; 3(3):e30. PubMed ID: 17335344
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice.
De Souza AT; Dai X; Spencer AG; Reppen T; Menzie A; Roesch PL; He Y; Caguyong MJ; Bloomer S; Herweijer H; Wolff JA; Hagstrom JE; Lewis DL; Linsley PS; Ulrich RG
Nucleic Acids Res; 2006; 34(16):4486-94. PubMed ID: 16945951
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.
Cariello NF; Romach EH; Colton HM; Ni H; Yoon L; Falls JG; Casey W; Creech D; Anderson SP; Benavides GR; Hoivik DJ; Brown R; Miller RT
Toxicol Sci; 2005 Nov; 88(1):250-64. PubMed ID: 16081524
[TBL] [Abstract][Full Text] [Related]
4. Identification of promethin and PGLP as two novel up-regulated genes in PPARgamma1-induced adipogenic mouse liver.
Yu S; Viswakarma N; Batra SK; Sambasiva Rao M; Reddy JK
Biochimie; 2004 Nov; 86(11):743-61. PubMed ID: 15589683
[TBL] [Abstract][Full Text] [Related]
5. Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate.
Currie RA; Bombail V; Oliver JD; Moore DJ; Lim FL; Gwilliam V; Kimber I; Chipman K; Moggs JG; Orphanides G
Toxicol Sci; 2005 Aug; 86(2):453-69. PubMed ID: 15901911
[TBL] [Abstract][Full Text] [Related]
6. Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acid.
Rosen MB; Abbott BD; Wolf DC; Corton JC; Wood CR; Schmid JE; Das KP; Zehr RD; Blair ET; Lau C
Toxicol Pathol; 2008 Jun; 36(4):592-607. PubMed ID: 18467677
[TBL] [Abstract][Full Text] [Related]
7. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
Meng RS; Pei ZH; Yin R; Zhang CX; Chen BL; Zhang Y; Liu D; Xu AL; Dong YG
Eur J Pharmacol; 2009 Oct; 620(1-3):63-70. PubMed ID: 19699196
[TBL] [Abstract][Full Text] [Related]
8. High-throughput selection of effective RNAi probes for gene silencing.
Kumar R; Conklin DS; Mittal V
Genome Res; 2003 Oct; 13(10):2333-40. PubMed ID: 14525931
[TBL] [Abstract][Full Text] [Related]
9. Quantitative inference of dynamic regulatory pathways via microarray data.
Chang WC; Li CW; Chen BS
BMC Bioinformatics; 2005 Mar; 6():44. PubMed ID: 15748298
[TBL] [Abstract][Full Text] [Related]
10. Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver.
Oishi K; Uchida D; Ishida N
FEBS Lett; 2008 Oct; 582(25-26):3639-42. PubMed ID: 18840432
[TBL] [Abstract][Full Text] [Related]
11. Analysis of PPARalpha-dependent and PPARalpha-independent transcript regulation following fenofibrate treatment of human endothelial cells.
Araki H; Tamada Y; Imoto S; Dunmore B; Sanders D; Humphrey S; Nagasaki M; Doi A; Nakanishi Y; Yasuda K; Tomiyasu Y; Tashiro K; Print C; Charnock-Jones DS; Kuhara S; Miyano S
Angiogenesis; 2009; 12(3):221-9. PubMed ID: 19357976
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential genomic biomarkers of hepatotoxicity caused by reactive metabolites of N-methylformamide: Application of stable isotope labeled compounds in toxicogenomic studies.
Mutlib A; Jiang P; Atherton J; Obert L; Kostrubsky S; Madore S; Nelson S
Chem Res Toxicol; 2006 Oct; 19(10):1270-83. PubMed ID: 17040096
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of novel and selective peroxisome proliferator-activated receptor alpha agonists with robust hypolipidemic activity in vivo.
Kane CD; Stevens KA; Fischer JE; Haghpassand M; Royer LJ; Aldinger C; Landschulz KT; Zagouras P; Bagley SW; Hada W; Dullea R; Hayward CM; Francone OL
Mol Pharmacol; 2009 Feb; 75(2):296-306. PubMed ID: 18971326
[TBL] [Abstract][Full Text] [Related]
14. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
[TBL] [Abstract][Full Text] [Related]
15. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.
Guo L; Fang H; Collins J; Fan XH; Dial S; Wong A; Mehta K; Blann E; Shi L; Tong W; Dragan YP
BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139
[TBL] [Abstract][Full Text] [Related]
16. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.
Lapinskas PJ; Brown S; Leesnitzer LM; Blanchard S; Swanson C; Cattley RC; Corton JC
Toxicology; 2005 Feb; 207(1):149-63. PubMed ID: 15590130
[TBL] [Abstract][Full Text] [Related]
17. Assessment of subclinical, toxicant-induced hepatic gene expression profiles after low-dose, short-term exposures in mice.
Zheng JL; Parfett C; Williams A; Yagminas A; Zhou G; Douglas GR; Yauk CL
Regul Toxicol Pharmacol; 2011 Jun; 60(1):54-72. PubMed ID: 21335049
[TBL] [Abstract][Full Text] [Related]
18. Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in rat hepatocytes.
Rogue A; Renaud MP; Claude N; Guillouzo A; Spire C
Toxicol Appl Pharmacol; 2011 Jul; 254(1):18-31. PubMed ID: 21515302
[TBL] [Abstract][Full Text] [Related]
19. Menin prevents liver steatosis through co-activation of peroxisome proliferator-activated receptor alpha.
Cheng P; Yang SS; Hu XG; Zhou XY; Zhang YJ; Jin G; Zhou YQ
FEBS Lett; 2011 Nov; 585(21):3403-8. PubMed ID: 22001208
[TBL] [Abstract][Full Text] [Related]
20. Alternative pathway approach for automating analysis and validation of cell perturbation networks and design of perturbation experiments.
Gong Y; Zhang Z
Ann N Y Acad Sci; 2007 Dec; 1115():267-85. PubMed ID: 17925355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
